Seven Eight Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-48,194
Closed -$979K 108
2024
Q3
$979K Sell
48,194
-69,529
-59% -$1.42M 0.09% 399
2024
Q2
$2.66M Buy
+117,723
New +$3.08M 0.28% 87
2023
Q4
Sell
-16,407
Closed -$460K 642
2023
Q3
$460K Buy
+16,407
New +$563K 0.05% 410
2022
Q2
Sell
-8,970
Closed -$282K 408
2022
Q1
$282K Buy
+8,970
New +$281K 0.04% 421
2021
Q4
Sell
-21,426
Closed -$623K 490
2021
Q3
$623K Buy
21,426
+100
+0.5% +$3.24K 0.06% 392
2021
Q2
$742K Buy
+21,326
New +$706K 0.1% 340
2020
Q2
Sell
-39,094
Closed -$347K 350
2020
Q1
$347K Buy
+39,094
New +$564K 0.09% 283
2019
Q4
Sell
-175,535
Closed -$2.62M 637
2019
Q3
$2.62M Sell
175,535
-12,741
-7% -$207K 0.14% 225
2019
Q2
$4.52M Buy
188,276
+182,600
+3,217% +$5.38M 0.24% 133
2019
Q1
$211K Buy
+5,676
New +$207K 0.01% 524
2018
Q4
Sell
-53,876
Closed -$2.13M 554
2018
Q3
$2.13M Buy
+53,876
New +$2.36M 0.13% 231
2018
Q2
Sell
-40,276
Closed -$1.96M 472
2018
Q1
$1.96M Buy
+40,276
New +$2.01M 0.16% 176
2017
Q4
Sell
-55,601
Closed -$2.81M 465
2017
Q3
$2.81M Sell
55,601
-13,300
-19% -$627K 0.34% 97
2017
Q2
$2.61M Buy
68,901
+61,200
+795% +$2.41M 0.38% 91
2017
Q1
$296K Buy
+7,701
New +$232K 0.06% 332

Other funds holding CC

Seven Eight Capital's CC Position: Q4 2024 in Review

Seven Eight Capital sold out of Chemours (CC) in Q4 2024, closing a stake of 48,194 shares — an estimated $979K sold.

Seven Eight Capital first reported a position in CC in Q1 2017 and held it in 15 quarters. The position peaked at $4.52M in Q2 2019. 441 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • Seven Eight Capital reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 48,194 Chemours shares in Q4 2024, an estimated $979K.
  • Seven Eight Capital first reported a position in Chemours in Q1 2017 and held it in 15 quarters.
  • Seven Eight Capital's Chemours position peaked at $4.52M in Q2 2019.
  • 441 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.